Tenax Therapeutics, Inc. · NASDAQ:TENX
Point72 Asset Management, L.P.'s stake in Tenax Therapeutics, Inc. fell to 3.10% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Point72 Asset Management, L.P.'s stake in Tenax Therapeutics, Inc. fell to 3.10%, 533,965 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 3.10%
- Shares
- 533,965
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 3.10% | 533,965 |
| Point72 Capital Advisors, Inc. | 3.10% | 533,965 |
| Steven A. Cohen | 3.10% | 533,965 |
Source
Related
- Tenax Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Oct 29, 2025
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026